Posts | Comments | Contact



CytRx Corp. (NASD:CYTR) Seasonal Chart

CytRx Corp. (NASD:CYTR) Seasonality

CYTR Relative to the S&P 500
CYTR Relative to the S&P 500

CYTR Relative to the Sector
CYTR Relative to the Sector

Monthly Seasonal CytRx Corp. (NASD:CYTR)

Seasonal Chart Analysis

Analysis of the CytRx Corp. (NASD:CYTR) seasonal charts above shows that a Buy Date of December 31 and a Sell Date of March 22 has resulted in a geometric average return of 24.73% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 49.36% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

CytRx Corp is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...